Development of Organometallic Ruthenium(II) Anticancer (RAPTA) Drugs

ISSN： 0009-4293

Source： CHIMIA International Journal for Chemistry, Vol.61, Iss.4, 2007-04, pp. : 140-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ruthenium(II) Arene Compounds as Versatile Anticancer Agents

By Renfrew Anna

CHIMIA International Journal for Chemistry, Vol. 63, Iss. 4, 2009-04 ,pp. : 217-219

Swiss Chemical Society

Access to resources Recommend Favorite

The Design of Organometallic Ruthenium Arene Anticancer Agents

By Dougan Sarah J. Sadler Peter J.

CHIMIA International Journal for Chemistry, Vol. 61, Iss. 11, 2007-11 ,pp. : 704-715

Swiss Chemical Society

Access to resources Recommend Favorite

Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells

CHEMISTRY - A EUROPEAN JOURNAL, Vol. 21, Iss. 43, 2015-10 ,pp. : 15308-15319

John Wiley & Sons Inc

Access to resources Recommend Favorite

Histone‐Deacetylase‐Targeted Fluorescent Ruthenium(II) Polypyridyl Complexes as Potent Anticancer Agents

CHEMISTRY - A EUROPEAN JOURNAL, Vol. 19, Iss. 31, 2013-07 ,pp. : 10160-10169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticancer Organometallic Osmium(II)‐p‐cymene Complexes

CHEMMEDCHEM, Vol. 10, Iss. 9, 2015-09 ,pp. : 1539-1547

John Wiley & Sons Inc

Access to resources Recommend Favorite